Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masaki Wato is active.

Publication


Featured researches published by Masaki Wato.


Digestive Endoscopy | 2013

Exposed blood vessels of more than 2 mm in diameter are a risk factor for rebleeding after endoscopic clipping hemostasis for hemorrhagic gastroduodenal ulcer.

Shigenao Ishikawa; Tomoki Inaba; Masaki Wato; Shiho Takashima; Tomoko Mizushige; Kouichi Izumikawa; Masatsugu Miyoshi; Kozo Kawai

There are few clinical studies on the risk factors for rebleeding based on the endoscopic hemostatic procedure carried out, including ulcer characteristics such as exposed blood vessels. The present study aims to clarify the risk factors for rebleeding after endoscopic clipping hemostasis for hemorrhagic gastroduodenal ulcers.


Hepato-gastroenterology | 2012

Characteristics of serious complicated gastroduodenal ulcers in Japan.

Shigenao Ishikawa; Tomoki Inaba; Motowo Mizuno; Yasuhiro Miyake; Hiroyuki Okada; Hisashi Ishikawa; Keisuke Hori; Masaki Wato; Kozo Kawai; Kazuhide Yamamoto

BACKGROUND/AIMS Even in Japan where the incidence of H. pylori infection is high, patients with gastroduodenal ulcers caused by NSAIDs are on the increase. A prospective study was conducted to elucidate the characteristics of gastroduodenal ulcers complicated with ulcerous hemorrhage and perforation among Japanese. METHODOLOGY The subjects were 305 consecutive cases with hemorrhaging ulcers and 76 consecutive cases with perforated ulcers basis at Kagawa Prefectural Central Hospital between January 2000 and December 2008. These subjects were divided into 3 groups (lowdose aspirin, non-aspirin NSAIDs and non-NSAIDs) and were further stratified by the presence of an H. pylori infection. RESULTS The 76 perforating ulcers were composed of 54 non-NSAIDs ulcers and 22 NSAIDs-related ulcers. The 305 hemorrhaging ulcers were composed of 156 non-NSAIDs ulcers, 94 non-aspirin NSAIDs ulcers and 55 on low-dose aspirin. The mortality for the non-aspirin NSAIDs group (12.8%, 12/94) and for the low-dose aspirin group (10.9%, 6/55) was significantly higher (p<0.01 and p<0.05, respectively) than the corresponding figure (2.6%, 4/156) for the non-NSAIDs group. The causes of death were exacerbation of or complications from the background diseases (Charlson Co-morbidity Index 3≤) (Odds ratios (OR) 6.01, 95% CI (1.98-18.89)). CONCLUSIONS Approximately 50% of the gastroduodenal ulcers with complications found in Japanese are NSAIDs-related and may take a fatal turn. It is necessary to take measures to prevent the complicated ulcers corresponding to risk factors such as the severity of background diseases.


Annals of Vascular Surgery | 2011

Endovascular repair and pharmacotherapy of an inflammatory abdominal aortic aneurysm complicated by primary aortoduodenal fistula.

Takanori Suezawa; Atsushi Aoki; Mamoru Tago; Norichika Iga; Koji Miyahara; Masaki Wato; Tomoki Inaba; Kozo Kawai

An inflammatory abdominal aortic aneurysm complicated by primary aortoduodenal fistula was successfully treated by stent grafting. Pharmacotherapy with octreotide after endovascular aneurysm repair was also performed with the expectation of spontaneous and rapid closure of the fistula. Gastrointestinal endoscopy performed 10 days after endovascular aneurysm repair showed closure of the large aortoduodenal fistula, and oral intake was started on the operative day 16. To date, 16 months after the initial operation, the patient is doing well without any symptoms or signs of infection and without any antibiotic therapy.


Endoscopy International Open | 2018

Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy

Tomo Kagawa; Shigenao Ishikawa; Tomoki Inaba; Mariko Colvin; Junki Toyosawa; Yuki Aoyama; Masaya Ishida; Sakiko Kuraoka; Kunio Okamoto; Ichiro Sakakihara; Koichi Izumikawa; Kumiko Yamamoto; Sakuma Takahashi; Shigetomi Tanaka; Mihoko Matsuura; Toshimi Hasui; Masaki Wato; Midori Ando; Satoko Nakamura; Koichi Mizobuchi

Background and study aims  Salvage therapy for esophageal cancer following chemo-radiation therapy (CRT) has not been established. We aimed to evaluate endoscopic submucosal dissection (ESD) as a salvage therapy based on histopathological features of lesions. Patients and methods  We compared 10 lesions in eight patients with local residual, recurrent, or metachronous esophageal squamous cell carcinoma treated by ESD after CRT (CRT group) and 59 lesions treated by ESD without CRT (non-CRT group) during the same period. Results  The en bloc resection rate was 100 % while the complete resection rate was 80.0 % in the lesions after CRT, indicating no difference between the CRT and non-CRT groups. Pathological examination showed that fibrosis was more intense in the lamina propria mucosa, muscularis mucosa, and submucosa. The muscularis mucosa was thicker in both non-tumor and tumor sites in the CRT group compared to the non-CRT group. However, severe submucosal fibrosis was observed only in one lesion in the CRT group. The maximum diameter of the submucosal artery was significantly larger in the CRT group ( P  < 0.001). Conclusions  Compared to the non-CRT group, the lesions in the CRT group were accompanied by fibrosis while the muscularis mucosa were thicker; however, severe fibrosis of the submucosa was rare. It is important to dissect the muscularis mucosa appropriately during ESD, which makes successful dissection of the submucosa possible. Attention should be paid to bleeding from large arteries.


Acta Medica Okayama | 2008

Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan.

Shigenao Ishikawa; Tomoki Inaba; Motowo Mizuno; Hiroyuki Okada; Kenji Kuwaki; Toshiaki Kuzume; Hitomi Yokota; Yasuyo Fukuda; Kou Takeda; Hiroshi Nagano; Masaki Wato; Kozo Kawai


Hepato-gastroenterology | 2010

Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc.

Tomoki Inaba; Shigenao Ishikawa; Tatsuya Toyokawa; Hisashi Ishikawa; Koji Miyahara; Masaki Wato; Kozo Kawai; Hiroyuki Okada; Kazuhide Yamamoto


Acta Medica Okayama | 1998

Relationship of serum markers of hepatitis B and C virus replication in coinfected patients.

Hideyuki Tsuji; Hiroyuki Shimomura; Kozo Fujio; Masaki Wato; Junichi Kondo; Toshimi Hasui; Yasushi Ishii; Shinichi Fujioka; Takao Tsuji


Hepato-gastroenterology | 1996

Detection of hepatitis C virus RNA in circulating immune complexes by RT-PCR

Takechiyo Morita; Hajime Hada; Norio Koide; Hidenori Shiraha; Toshiyuki Shinji; Masaki Nakamura; Kouzo Ujike; Masaki Wato; Hiroyuki Shimomura; Takao Tsuji


Acta Medica Okayama | 1994

Quantitation of Hepatitis C Virus RNA in Liver Tissue as a Predictive Marker of the Response to Interferon Therpay in Chronic Hepatitis C

Toshimi Hasui; Hiroyuki Shimomura; Hideyuki Tsuji; Masaki Wato; Takao Tsuji


Acta Medica Okayama | 1995

Virological and serological characterization of asymptomatic blood donors positive for anti-hepatitis C virus antibody.

Hideyuki Tsuji; Hiroyuki Shimomura; Masaki Wato; Junichi Kondo; Takao Tsuji

Collaboration


Dive into the Masaki Wato's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge